Approved for 1 INDICATIONS AND USAGE NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. NAMENDA is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 ). 12.1 Mechanism of Action Persistent activation of central nervous system…
Loading full data from Know Your Drugs Institute…